Cost-effective, easily manufactured ventilators for COVID-19 patients

  • The Mechanical Ventilator Milano design helps overcome the ventilator shortage, aids with the respiratory effects of the pandemic.


WASHINGTON, USA (March 23, 2021) — Scientists have been working for the past year to find ways to curb the effects of the COVID-19 pandemic. Though it is outside their typical realm of study, physicists have been playing an important role in many aspects of research about the pandemic and its impact on people.

Particle physicists’ keen understanding of gas handling systems positioned them at the forefront for pioneering low-cost, mass-producible ventilators to help address the worldwide shortage. Led by Cristian Galbiati, professor of physics at Princeton University and the Gran Sasso Science Institute, an international, interdisciplinary team called the Mechanical Ventilator Milano (MVM) collaboration spearheaded one effort and presents the design in the journal Physics of Fluids, from AIP Publishing.

The project began in March 2020, shortly after Italy went into lockdown. Only one week later, the MVM collaboration had a working prototype.

The ventilator consists of a gas inlet valve and a gas outlet valve, along with a series of controls and alarms to ensure proper monitoring and customizability from patient to patient. The design is built from readily available parts and is presented under an open license, allowing developing countries to quickly and easily manufacture their own units.

“The idea behind the design was to have a system as simple as possible — delivery of air through a single valve, exhaust of air through a single valve,” said Galbiati.

Because the MVM is developed specifically for COVID-19 patients, it has reduced functionality compared to typical ventilators. This simpler design cuts the cost of production up to fivefold to under $10,000 per unit.

“This pandemic comes upon us, and you feel somewhat helpless as someone who isn’t a medical physicist,” said physics Nobel laureate Arthur McDonald, at Queen’s University and a co-author on the paper. “Our collaboration of particle physicists, engineers, and software specialists from national labs, academia, and industry have applied their existing talents to create a new, accessible design and to provide a new manufacturing capability internationally to address the most serious cases during the pandemic.”

“For a scientist committed to fundamental research, such as the search for the dark matter of the universe, it is extremely important to devote time and experience to build devices that can help to improve people’s health,” said Walter Bonivento, a senior scientist at INFN Cagliari and co-author on the paper.

The MVM has already received emergency use authorization from the U.S. Food and Drug Administration and received Health Canada Medical Device Directorate authorization. About 6,000 units have been delivered to date under a contract from the Canadian government for its stockpile, with the potential for more, if requested. Donations from Canada to developing countries in need have also been considered from the beginning of the contract award.





More information about the project can be found on the MVM Collaboration website.

The article “The novel Mechanical Ventilator Milano for the COVID-19 pandemic” is authored by A. Abba, C. Accorsi, P. Agnes, E. Alessi, P. Amaudruz, A. Annovi, F. Ardellier Desages, S. Back, C. Badia, J. Bagger, V. Basile, G. Batignani, A. Bayo, B. Bell, M. Beschi, D. Biagini, G. Bianchi, S. Bicelli, D. Bishop, T. Boccali, A. Bombarda, S. Bonfanti, W.M. Bonivento, M. Bouchard, M. Breviario, S. Brice, R. Brown, J.M. Calvo-Mozota, L. Camozzi, M. Camozzi, A. Capra, M. Caravati, M. Carlini, A. Ceccanti, B. Celano, J.M. Cela Ruiz, C. Charette, G. Cogliati, M. Constable, C. Crippa, G. Croci, S. Cudmore, C.E. Dahl, A. Dal Molin, M. Daley, C. Di Guardo, G. D’Avenio, O. Davignon, M. Del Tutto, J. De Ruiter, A. Devoto, P. Diaz Gomez Maqueo, F. Di Francesco, M. Dossi, E. Druszkiewicz, C. Duma, E. Elliott, D. Farina, C. Fernandes, F. Ferroni, G. Finocchiaro, G. Fiorillo, R. Ford, G. Foti, R.D. Fournier, D. Franco, K. Frickbergs, F. Gabriele, C. Galbiati, P. Garcia Abia, A. Gargantini, L. Giacomelli, F. Giacomini, F. Giacomini, L.S. Giarratana, S. Gillespie, D. Giorgi, T. Girma, R. Gobui, D. Goeldi, F. Golf, P. Gorel, G. Gorini, E. Gramellini, G. Grosso, F. Guescini, E. Guetre, G. Hackman, T. Hadden, W. Hawkins, K. Hayashi, A. Heavey, G. Hersak, N. Hessey, G. Hockin, K. Hudson, A. Ianni, C. Ienzi, V. Ippolito, C.C. James, C. Jillings, C. Kendziora, S. Khan, E. Kim, M. King, S. King, A. Kittmer, I. Kochanek, J. Kowalkowski, R. Krücken, M. Kushoro, S. Kuula, M. Laclaustra, G. Leblond, L. Lee, A. Lennarz, M. Leyton, X. Li, P. Liimatainen, C. Lim, T. Lindner, T. Lomonaco, P. Lu, R. Lubna, G.A. Lukhanin, G. Luzón, M. MacDonald, G. Magni, R. Maharaj, S. Manni, C. Mapelli, P. Margetak, L. Martin, S. Martin, M. Martínez, N. Massacret, P. McClurg, A.B. McDonald, E. Meazzi, R. Migalla, T. Mohayai, L. Molinari Tosatti, G. Monzani, C. Moretti, B. Morrison, M. Mountaniol, A. Muraro, P. Napoli, F. Nati, C. Natzke, A.J. Noble, A. Norrick, K. Olchanski, A. Ortiz de Solorzano, F. Padula, M. Pallavicini, I. Palumbo, E. Panontin, N. Papini, L. Parmeggiano, S. Parmeggiano, K. Patel, A. Patel, M. Paterno, C. Pellegrino, P. Pelliccione, V. Pesudo, A. Pocar, A. Pope, S. Pordes, F. Prelz, O. Putignano, J.L. Raaf, C. Ratti, M. Razeti, A. Razeto, D. Reed, J. Refsgaard, T. Reilly, A. Renshaw, F. Retriere, E. Riccobene, D. Rigamonti, A. Rizz, J. Rode, J. Romualdez, L. Russel, D. Sablone, S. Sala, D. Salomoni, P. Salvo, A. Sandoval, E. Sansoucy, R. Santorelli, C. Savarese, E. Scapparone, T. Schaubel, S. Scorza, M. Settimo, B. Shaw, S. Shawyer, A. Sher, A. Shi, P. Skensved, A. Slutsky, B. Smith, N.J.T. Smith, A. Stenzler, C. Straubel, P. Stringari, M. Suchenek, B. Sur, S. Tacchino, L. Takeuchi, M. Tardocchi, R. Tartaglia, E. Thomas, D. Trask, J. Tseng, L. Tseng, L. VanPagee, V. Vedia, B. Velghe, S. Viel, A. Visioli, L. Viviani, D. Vonica, M. Wada, D. Walter, H. Wang, M.H.L.S. Wang, S. Westerdale, D. Wood, D. Yates, S. Yue, and V. Zambrano. The article will appear in Physics of Fluids on March 23, 2021 (DOI: 10.1063/5.0044445).
After that date, it can be accessed at



Physics of Fluids is devoted to the publication of original theoretical, computational, and experimental contributions to the dynamics of gases, liquids, and complex fluids. See



IMAGE: The Mechanical Ventilator Milano, developed by an international, interdisciplinary team, is inexpensive and simple to manufacture, and has received authorization from U.S. and Canadian agencies. Credit: MVM Collaboration



American Institute of Physics, 23.03.2021 (tB).

Schlagwörter: ,


Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds


Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern


„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 
Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…


Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren


Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung


NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose


Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung